ADVERTISEMENT

Beyond the headlines: A closer look at the USPSTF draft recs on aspirin

The Journal of Family Practice. 2021 November;70(9):audio
October 26, 2021|The Journal of Family Practice
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a clinical professor at the University of Arizona College of Medicine, a senior lecturer with the University of Arizona College of Public Health, and a member of the US Community Preventive Services Task Force. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflict of interest relevant to this audiocast.

The US Preventive Services Task Force recently made big news with its draft update that recommends against the initiation of low-dose aspirin for primary prevention of cardiovascular disease in patients ≥ 60 years. But there are other aspects of the draft that family physicians need to know about. This month, Dr. Campos-Outcalt provides a closer look at the draft recommendations and discusses which patients should initiate—or continue taking—daily low-dose aspirin.

REFERENCES

  1. US Preventive Services Task Force. Aspirin use to prevent cardiovascular disease: preventive medication. Published October 12, 2021. Accessed October 25, 2021. www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
  2. National Center for Health Statistics. Figure 4. Number of deaths, percentage of total deaths, and age-adjusted death rates for the 10 leading causes of death in 2019: United States, 2018 and 2019. In: Data Brief 395: Mortality in the United States 2019. Published December 2020. Accessed October 25, 2021. www.cdc.gov/nchs/data/databriefs/db395-tables-508.pdf
  3. American College of Cardiology/American Heart Association. Heart risk calculator. Updated November 12, 2017. Accessed October 25, 2021. www.cvriskcalculator.com/

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT